Navigation Links
Wounded Warriors a Focus of the 12th New Jersey Symposium on Biomaterials Science
Date:8/1/2014

Piscataway, NJ (PRWEB) August 02, 2014

For the past five years, the New Jersey Center for Biomaterials under the auspices of the Armed Forces Institute of Regenerative Medicine (AFIRM) has led a consortium of academic research organizations in the development of advanced treatment options for our severely wounded warriors. AFIRM is a multi-institutional, inter¬disciplinary network working to develop new products and therapies to treat severe injuries suffered by US servicemen and women in the current wars. The AFIRM teams, working in research laboratories and clinics across the country, are advancing biological therapies (including adult stem cells and growth factors), tissue and biomaterials engineering, and advanced transplantation methods. These new treatments will enable the body to repair, replace, restore and regenerate damaged tissues and organs.

The 12th New Jersey Symposium on Biomaterials Science will focus several presentations on the regeneration of nerves and muscle resulting from catastrophic peripheral nerve injury and muscular tissue loss for Wounded Warriors. These types of injuries to the body’s soft tissue are leading sources of lifelong disability. Extreme trauma from combat wounds can cause nerve injuries that create gaps in the nerves leading to the muscles of the limbs. The success in this work for our Wounded Warriors is readily translatable to injuries suffered by the civilian population resulting from industrial and automobile accidents.

Registration for the 12th NJ Symposium on Biomaterials Science is available at http://www.njbiomaterials.org/biomaterials-symposia.htm.

The New Jersey Center for Biomaterials (NJCBM) was founded in 1997. Based at Rutgers, the State University of New Jersey, the center spans academia, industry, and government. Staffed by biomaterial scientists, the Center works to improve health care and quality of life by developing advanced biomedical products for tissue repair and replacement as well as the delivery of pharmaceutical agents. The Center’s technologies have been translated into clinical and pre-clinical products including surgical meshes, cardiovascular stents, bone regeneration scaffolds, and ocular drug delivery systems.

Media Contact:

Louli Kourkounakis
(732) 445 0488 ext. 40001
symposium(at)dls(dot)rutgers(dot)edu

Read the full story at http://www.prweb.com/releases/2014/08/prweb12062870.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
2. Model Aviation Clubs Raise $76,000 for the Wounded Warrior Project
3. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
4. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
5. Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research
6. Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities
7. Vermillion Sharpens Focus and Streamlines Operations in 2012
8. Inverseon Focuses on Mucous and Smoking Cessation
9. First Statewide Biotech Meeting Focuses on Patient Access, Innovation
10. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
11. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 /PRNewswire/ ... and Beyond Type 1, a not-for-profit advocacy and education ... announced a grant from Beyond Type 1 to support ... 1 and other insulin-requiring diabetes.  For ... stem cell-derived cell replacement therapies with a focus on ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
(Date:2/22/2017)... ... February 22, 2017 , ... ProMIS Neurosciences ... treatments for neurodegenerative diseases, today announced it has issued a scientific white paper ... one of a series of commentaries from ProMIS’s scientific team offering insight into ...
(Date:2/22/2017)... -- Origin (Origin Agritech, LLC, a subsidiary of Origin Agritech Ltd.) ... Arcadia (Arcadia Biosciences, Inc., NASDAQ: RKDA), a ... traits and nutritional products, today announced their collaboration to achieve the ... China to the United States ... ...
Breaking Biology Technology:
(Date:2/2/2017)... , Feb. 2, 2017  EyeLock LLC, a market ... new white paper " What You Should Know About ... of ensuring user authenticity is a growing concern. In ... of users. However, traditional authentication schemes such as username/password ... Biometric authentication offers an elegant solution to the ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, business ... new report, Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027 ... ... Revenues of ... for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force sensing ...
(Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... growing genetic information companies, today announced that it will ... and provide 2017 guidance on Monday, February 13, 2017, ... that day at 4:45 p.m. Eastern / 1:45 p.m. ... team will briefly review financial results, guidance, and recent ...
Breaking Biology News(10 mins):